$3.0m CRC-P grant to VivaZome Therapeutics and Partners for Customised Exosome Therapy

Posted: 24 January

VivaZome Therapeutics Pty Ltd is delighted to announce that it has been awarded an Australian Government Round 13 CRC-P grant of $3.0m in support of the project “Customised exosomes – the future of regenerative medicine”.

The Hon Ed Husic MP, Minister for Industry and Science, who oversees the Cooperative Research Centre Projects (CRC-P) Grants Scheme announced the successful Round 13 applications today. The scheme supports the development of innovative Australian companies and sectors, and promotes collaboration between small companies, large companies and academic institutions.

Joining VivaZome in the CRC-P are five Australian project partners, bringing high-level scientific, technical and operational capability to the 3–year project. The partner organisations and the key project leaders at each are:
• La Trobe University: Dr Lesley Cheng, Group Leader, Neurodegeneration Biology and Biomarker Group, La Trobe Institute for Molecular Sciences (LIMS)
• The University of Queensland: Professor David Reutens, Director of the Centre for Advanced Imaging
• Australian National University: Professor Riccardo Natoli, Group Leader – Clear Vision Research
• Cytiva: Professor Tim O’Meara, Strategy Manager – Government & Research, ANZ
• SeerPharma Pty Ltd: Mr Paul Kerr, Director

Find out more.


News & opinion

Member Directory